Back to search

Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

Data up to Jan 2025

Published1999
Citations676
References83

Total Citations Per Year

Abstract

References (83)

Meta-analysis in clinical trials

1986 • 36,193 citations

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

The American Journal of Human Genetics

1950 • 5,048 citations

Tamoxifen for early breast cancer: an overview of the randomised trials

1998 • 4,082 citations

Risk Factors for Hip Fracture in White Women

1995 • 3,589 citations

The cardiovascular health study: Design and rationale

1991 • 3,584 citations

Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

1989 • 3,239 citations

Cancer Epidemiology and Prevention

2006 • 3,228 citations

Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism

1998 • 2,620 citations

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1998 • 2,456 citations

The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews

1997 • 2,255 citations

Guide to Clinical Preventive Services

1991 • 2,175 citations

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

1997 • 1,783 citations

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1995 • 1,602 citations

Perspective how many women have osteoporosis?

1992 • 1,379 citations

Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening Study

1995 • 1,095 citations

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

1999 • 1,034 citations

Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death.

1953 • 1,009 citations

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1994 • 955 citations

Principles and Practice of Gynecologic Oncology

1992 • 933 citations

Genetic analysis of breast cancer in the cancer and steroid hormone study.

1991 • 915 citations

Endometrial Carcinoma

1990 • 910 citations

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1998 • 890 citations

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

1998 • 876 citations

Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status

1995 • 860 citations

Stroke Incidence and Survival Among Middle-Aged Adults

1999 • 778 citations

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

1998 • 774 citations

Cardiovascular Disease in Women

1997 • 754 citations

Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence

1999 • 743 citations

Breast Cancer

1992 • 695 citations

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.

1990 • 633 citations

The Lens Opacities Case-Control Study

1991 • 594 citations

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1996 • 580 citations

Racial/ethnic patterns of cancer in the United States, 1988-1992.

1996 • 512 citations

A REVIEW OF THE EPIDEMIOLOGY OF HUMAN BREAST CANCER

1979 • 461 citations

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

1998 • 453 citations

Endometrial Carcinoma

1996 • 448 citations

Basic Epidemiology of Fractures of the Upper and Lower Limb among Americans over 65 Years of Age

1996 • 432 citations

Epidemiology of Endometrial Cancer 2

1977 • 430 citations

Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of Age

1995 • 412 citations

Pulmonary Embolism

1998 • 412 citations

The epidemiology of endometrial cancer

1991 • 403 citations

A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors

1989 • 400 citations

Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer.

1997 • 384 citations

Probability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family History

1997 • 379 citations

Incidence rates of stroke in the eighties: the end of the decline in stroke?

1989 • 367 citations

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1998 • 352 citations

Frequency of Breast Cancer Attributable to <EMPH TYPE="ITAL">BRCA1</EMPH> in a Population-Based Series of American Women

1998 • 350 citations

Tumour biological features of BRCA1-induced breast and ovarian cancer

1997 • 346 citations

What is the relationship between breast cancer risk and mammography screening? A meta-analytic review.

1996 • 340 citations

Estrogen-Progestin Replacement Therapy and Endometrial Cancer

1997 • 314 citations

Short-term Predictors of Incident Stroke in Older Adults

1996 • 300 citations

What is the relationship between breast cancer risk and mammography screening? A meta-analytic review.

1996 • 265 citations

Decreased incidence of hip fracture in Hispanics, Asians, and blacks: California Hospital Discharge Data.

1988 • 256 citations

Cancer Prevention

1986 • 255 citations

Randomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy

1998 • 250 citations

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.

1996 • 240 citations

Validation of the Gail et al. Model for Predicting Individual Breast Cancer Risk

1994 • 236 citations

Risk Factors for Age-related Cataracts

1995 • 234 citations

Hip fracture incidence among the old and very old: a population-based study of 745,435 cases.

1990 • 222 citations

Increasing Incidence of Endometrial Cancer in the United States

1976 • 210 citations

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

1998 • 185 citations

Incidence of Age-Related Cataract

1998 • 184 citations

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1997 • 177 citations

Validation of a Breast Cancer Risk Assessment Model in Women With a Positive Family History

1994 • 177 citations

Cowden syndrome.

1995 • 163 citations

INCIDENCE ESTIMATES FOR LENS CHANGES, MACULAR CHANGES, OPEN-ANGLE GLAUCOMA AND DIABETIC RETINOPATHY

1983 • 135 citations

Effect of BRCA1 and BRCA2 on the Association Between Breast Cancer Risk and Family History

1998 • 133 citations

A population-based model of risk factors for ischemic stroke

1996 • 127 citations

New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive Agent

1991 • 111 citations

BRCA1-related breast cancer in Austrian breast and ovarian cancer families: SpecificBRCA1 mutations and pathological characteristics

1998 • 98 citations

Tamoxifen and Endometrial Cancer

1994 • 97 citations

Long-term tamoxifen treatment for breast cancer

1994 • 90 citations

Hospitalized stroke in blacks and Hispanics in northern Manhattan.

1991 • 86 citations

A Reevaluation of the Risk for Venous Thromboembolism With the Use of Oral Contraceptives and Hormone Replacement Therapy

1997 • 82 citations

Risk Factors for Nuclear Opalescence in a Longitudinal Study

1998 • 63 citations

Tamoxifen and endometrial cancer

1996 • 62 citations

Differences in Prevalence of and Risk Factors for Subclinical Vascular Disease Among Black and White Participants in the Cardiovascular Health Study

1998 • 62 citations

Low-Dose Aspirin and Risks of Cataract in a Randomized Trial of US Physicians

1991 • 48 citations

Incidence and Progression of Cortical, Nuclear, and Posterior Subcapsular Cataracts

1994 • 41 citations

Risk-adjusted cancer-incidence rates (United States)

1996 • 39 citations

A Computer Program for Estimating Individualized Probabilities of Breast Cancer

1993 • 35 citations

Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer.

1998 • 13 citations

Cited By (0)

No citing papers found in database

Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer (1999) – JNCI Journal of the National Cancer Institute | Metascience Observatory Explorer